Methods for treating or preventing asthma by administering an il-4r antagonist

Disclosed is the use of an anti-IL4R antibody in the manufacture of a medicament for the reduction of asthma exacerbations/improving asthma-related parameters in a subject with eosinophilic asthma. Also disclosed is the use of an anti-IL4R antibody in the manufacture of a medicament for reducing dep...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Radin, Allen, Rocklin, Ross, Davidson Hamilton, Jennifer, Ardeleanu, Marius, Weinstein, Steven, Kirkesseli, Stephane, Ming, Jeffrey, Graham, Neil, Gandhi, Namita, Kundu, Sudeep
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed is the use of an anti-IL4R antibody in the manufacture of a medicament for the reduction of asthma exacerbations/improving asthma-related parameters in a subject with eosinophilic asthma. Also disclosed is the use of an anti-IL4R antibody in the manufacture of a medicament for reducing dependence on inhaled corticosteroids and/or long-acting beta-agonists in a subject with eosinophilic asthma.